rs9951026 — LIPG

LIPG rs9951026 — The Lipid Haplotype That Responds to How Much You Move

Endothelial lipase (EL), encoded by the LIPG gene on chromosome 18, is the primary enzyme responsible for breaking down the phospholipid surface of HDL particles¹¹ HDL particles
High-density lipoprotein — the "good cholesterol" carrier that transports cholesterol from peripheral tissues back to the liver for clearance. Unlike lipoprotein lipase (which targets triglyceride-rich VLDL and chylomicrons), EL preferentially hydrolyzes HDL phospholipids. Higher EL activity accelerates HDL catabolism, reducing circulating HDL-C. The rs9951026 variant is an intronic tag SNP in LIPG that marks a broader haplotype structure associated with modestly altered LDL cholesterol and apolipoprotein B levels — with an important twist: the effect on lipid profiles is substantially modified by physical activity.

The Mechanism

As a non-coding intronic variant, rs9951026 does not directly change any amino acid in the endothelial lipase protein. Its association with lipid traits derives from linkage disequilibrium²² linkage disequilibrium
LD — the tendency for nearby genetic variants to be inherited together on the same chromosomal segment, so that one variant predicts the presence of another with functional regulatory variants in the same LIPG haplotype block. The TTACA LIPG haplotype — spanning rs2000812, rs2000813, rs8093249, rs2276269, and rs9951026 — has been associated with higher LDL cholesterol and apolipoprotein B concentrations in population studies, suggesting the haplotype affects either LIPG expression levels or broader lipoprotein remodeling through regulatory elements in the same LD block.

LIPG expression is upregulated by pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6³³ pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6
The inflammatory connection explains why conditions like atherosclerosis, infection, and metabolic syndrome all tend to lower HDL-C — inflammation drives LIPG activity, which then degrades HDL faster. Physical activity suppresses this inflammatory signaling, which may explain why the lipid associations at rs9951026 are primarily visible in sedentary individuals: active individuals have lower baseline LIPG expression through reduced inflammation, partially neutralizing the haplotype effect.

The Evidence

Salazar-Tortosa et al. (2022)⁴⁴ Salazar-Tortosa et al. (2022)
Interplay of physical activity and genetic variants of the endothelial lipase on cardiovascular disease risk factors; 1,057 European adolescents from the HELENA Study aged 12–18 years; Pediatric Research found that the minor G allele of rs9951026 was associated with lower CVD risk factors related to the lipid profile. Critically, the beneficial allele associations were observed specifically in physically active adolescents — not in sedentary participants. The gene-physical activity interaction was statistically significant for rs9951026 (along with rs2000813 and rs2276269), indicating that the genetic effect on cardiovascular risk factors depends substantially on activity level.

The broader LIPG haplotype context comes from Hutter et al. (2006)⁵⁵ Hutter et al. (2006)
Association of endothelial lipase gene haplotypes with HDL cholesterol subfractions and apolipoprotein AI plasma levels in Japanese Americans; 541 adult participants; Atherosclerosis, which found that LIPG haplotypes — including variants at the same chromosomal region as rs9951026 — influenced HDL3 cholesterol (p=0.005) and apolipoprotein A-I levels (p=0.002), with favorable haplotype combinations showing lower apolipoprotein B and LDL cholesterol (p=0.001 and p=0.015 respectively).

Edmondson et al. (2009)⁶⁶ Edmondson et al. (2009)
Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans; 585 participants with extreme HDL phenotypes plus meta-analysis of ~3,845 participants; J Clin Invest established the fundamental LIPG-HDL relationship: rare loss-of-function mutations in LIPG raise HDL by approximately 8–11 mg/dL (10–16%), validating EL as a key determinant of circulating HDL levels in humans. While rs9951026 is not a loss-of-function variant, it sits in a haplotype context that modulates EL's functional output.

Practical Actions

The most important insight from the evidence is the gene-activity interaction: the A allele haplotype's association with less favorable lipid levels is attenuated or reversed in physically active individuals. This is not a reason to reduce cardiorespiratory training — it is a signal that your genetic lipid risk from this variant is disproportionately responsive to activity levels compared to the population average. Cardiovascular exercise reduces systemic inflammation, which in turn suppresses LIPG expression and slows HDL catabolism, partially compensating for an unfavorable LIPG haplotype.

For AA homozygotes, the standard lipid panel remains the key monitoring tool. Saturated fat quality, omega-3 intake, and aerobic activity are the primary levers — and for this genotype, activity matters more than average. Regular fasting lipid panels (including LDL-C and apolipoprotein B if available) provide the most actionable feedback.

Interactions

rs9951026 is part of a multi-SNP LIPG haplotype that includes rs2000813 (the Thr111Ile coding variant), rs3813082, and rs2276269. Haplotype analyses consistently show stronger lipid associations than any single SNP from this block. The rs2000813 T allele tags a 5'UTR regulatory variant (rs34474737) that reduces LIPG promoter activity; individuals carrying the full TTACA haplotype carry both the rs9951026 A allele and the rs2000813 T allele, with the combined haplotype showing stronger LDL and apoB associations than either SNP alone.

The gene-physical inactivity interaction found for nearby rs6507931 (LIPG i24582) in the GOLDN study — where screen time above 2.6 h/day reduced HDL-C and HDL particle size specifically in TT carriers — suggests a general pattern of LIPG-activity interaction across the gene's haplotype structure. Users with both rs9951026 AA (high-risk LIPG haplotype) and rs2000813 CC (standard EL expression, no HDL-raising regulatory haplotype benefit) represent a combined LIPG context where aerobic activity is particularly valuable for maintaining HDL quality.